Literature DB >> 34190409

A Membrane-Targeting Photosensitizer with Aggregation-Induced Emission Characteristics for Highly Efficient Photodynamic Combat of Human Coronaviruses.

Ming-Yu Wu1,2, Meijia Gu3, Jong-Kai Leung1, Xinmei Li4, Yuncong Yuan4, Chao Shen4, Lianrong Wang3, Engui Zhao5, Sijie Chen1.   

Abstract

COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2, has resulted in global social and economic disruption, putting the world economy to the largest global recession since the Great Depression. To control the spread of COVID-19, cutting off the transmission route is a critical step. In this work, the efficient inactivation of human coronavirus with photodynamic therapy (PDT) by employing photosensitizers with aggregation-induced emission characteristics (DTTPB) is reported. DTTPB is designed to bear a hydrophilic head and two hydrophobic tails, mimicking the structure of phospholipids on biological membranes. DTTPB demonstrates a broad absorption band covering the whole visible light range and high molar absorptivity, as well as excellent reactive oxygen species sensitizing ability, making it an excellent candidate for PDT. Besides, DTTPB can target membrane structure, and bind to the envelope of human coronaviruses. Upon light irradiation, DTTPB demonstrates highly effective antiviral behavior: human coronavirus treated with DTTPB and white-light irradiation can be efficiently inactivated with complete loss of infectivity, as revealed by the significant decrease of virus RNA and proteins in host cells. Thus, DTTPB sensitized PDT can efficiently prevent the infection and the spread of human coronavirus, which provides a new avenue for photodynamic combating of COVID-19.
© 2021 The Authors. Small published by Wiley-VCH GmbH.

Entities:  

Keywords:  aggregation-induced emission; human coronaviruses; membrane targeting; photodynamic therapy; photosensitizers

Year:  2021        PMID: 34190409     DOI: 10.1002/smll.202101770

Source DB:  PubMed          Journal:  Small        ISSN: 1613-6810            Impact factor:   13.281


  7 in total

1.  Sera Metabolomics Characterization of Patients at Different Stages in Wuhan Identifies Critical Biomarkers of COVID-19.

Authors:  Meijia Gu; Huaqin Pan; Yuncong Yuan; Xuemin Zhou; Luojia Chen; Xingran Wang; Fang Fang; Liu Hu; Yaxuan Xie; Chao Shen
Journal:  Front Cell Infect Microbiol       Date:  2022-05-02       Impact factor: 6.073

2.  A cell membrane-targeting AIE photosensitizer as a necroptosis inducer for boosting cancer theranostics.

Authors:  Niu Niu; Ying Yu; Zhijun Zhang; Miaomiao Kang; Lei Wang; Zheng Zhao; Dong Wang; Ben Zhong Tang
Journal:  Chem Sci       Date:  2022-04-19       Impact factor: 9.969

3.  Simultaneous Photodynamic Eradication of Tooth Biofilm and Tooth Whitening with an Aggregation-Induced Emission Luminogen.

Authors:  Meijia Gu; Susu Jiang; Xiaoyu Xu; Ming-Yu Wu; Chao Chen; Yuncong Yuan; Qingrong Chen; Yidan Sun; Luojia Chen; Chao Shen; Peng Guo; Shujie Liu; Engui Zhao; Shi Chen; Sijie Chen
Journal:  Adv Sci (Weinh)       Date:  2022-05-07       Impact factor: 17.521

Review 4.  Aspects of Antiviral Strategies Based on Different Phototherapy Approaches: Hit by the Light.

Authors:  Hannah Kunstek; Fanny Vreken; Aminata Keita; Michael R Hamblin; Florence Dumarçay; Mihayl Varbanov
Journal:  Pharmaceuticals (Basel)       Date:  2022-07-13

5.  Single-molecule photosensitizers for NIR-II fluorescence and photoacoustic imaging guided precise anticancer phototherapy.

Authors:  Hua Gu; Weijian Liu; Wen Sun; Jianjun Du; Jiangli Fan; Xiaojun Peng
Journal:  Chem Sci       Date:  2022-07-18       Impact factor: 9.969

6.  Photodynamic Inactivation of Human Coronaviruses.

Authors:  Brett A Duguay; Adrian Herod; Eric S Pringle; Susan M A Monro; Marc Hetu; Colin G Cameron; Sherri A McFarland; Craig McCormick
Journal:  Viruses       Date:  2022-01-08       Impact factor: 5.048

Review 7.  Metal-based complexes against SARS-CoV-2.

Authors:  Kyriacos Ioannou; Manos C Vlasiou
Journal:  Biometals       Date:  2022-03-24       Impact factor: 3.378

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.